President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Daiichi Sankyo-partnered anti-HER2 drug Enhertu (trastuzumab deruxtecan) has been cleared by the European Commission for use ...

Ociperlimab is described as a humanised IgG1 monoclonal antibody with the potential to enhance T cell-mediated immune ...

BeiGene ends its Phase 3 lung cancer trial for ociperlimab after a futility analysis. No new safety concerns were found, and study results will be shared later.

During a live event, James W. Smithy, MD, MHS, and other oncologists discussed the tolerability of different immune ...

A new form of tumor infiltrating lymphocyte therapy, a form of personalized cancer immunotherapy, improved the treatment’s ...

Researchers Uncover Link Between Omega 6 Fatty Acid and Aggressive Breast CancerLinoleic acid, an omega-6 fatty acid enhanced ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

According to the private global space research and consulting firm Novaspace, a total of 1,842 satellites were launched into ...

Mass firings hit U.S. health agencies over the past week, but disruptions to the nation’s medical research system have been ...

As U.S. President Donald Trump takes aim at the mostly American-owned pharmaceutical factories that dot the Irish countryside ...

Iovance stock drops 90% despite historic approval for Amtagvi. Click here for a full investment analysis of IOVA stock.